| scholarly article | Q13442814 |
| P50 | author | Rene E Toes | Q42494390 |
| P2093 | author name string | Jacob M van Laar | |
| René R P de Vries | |||
| Willem van Ewijk | |||
| Mary E Morgan | |||
| Leonie M van Duivenvoorde | |||
| Roelof Flierman | |||
| Hendrik J Witteveen | |||
| P2860 | cites work | Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells | Q34189120 |
| A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. | Q54023198 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 2212-2221 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. | |
| P478 | volume | 52 |
| Q52725822 | A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials. |
| Q35986133 | Abatacept decreases disease activity in a absence of CD4(+) T cells in a collagen-induced arthritis model. |
| Q36302388 | Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis |
| Q47572144 | Adoptive Induced Antigen-Specific Treg Cells Reverse Inflammation in Collagen-Induced Arthritis Mouse Model |
| Q35190547 | Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation |
| Q33828647 | Analysis of the transcriptional program of developing induced regulatory T cells |
| Q37382486 | Antigen-specific gene therapy after immunisation reduces the severity of collagen-induced arthritis. |
| Q35190507 | Antigen-specific transforming growth factor β-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance. |
| Q37169431 | Apoptotic cell infusion treats ongoing collagen-induced arthritis, even in the presence of methotrexate, and is synergic with anti-TNF therapy. |
| Q37350857 | Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: a potential cell-based therapy? |
| Q28541811 | Artesunate abolishes germinal center B cells and inhibits autoimmune arthritis |
| Q38872112 | Arthritis models: usefulness and interpretation |
| Q34776189 | Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis |
| Q46083861 | Blocking of p38 and transforming growth factor β receptor pathways impairs the ability of tolerogenic dendritic cells to suppress murine arthritis. |
| Q36600237 | CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance |
| Q34012863 | CD4+CD25+ regulatory T cells in autoimmune arthritis |
| Q36076203 | CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling |
| Q37754524 | CD4+CD25+ regulatory T-cell therapy |
| Q48152945 | CTLA-4 expressed by FOXP3+ regulatory T cells prevents inflammatory tissue attack and not T-cell priming in arthritis. |
| Q33792909 | Caerulomycin A enhances transforming growth factor-β (TGF-β)-Smad3 protein signaling by suppressing interferon-γ (IFN-γ)-signal transducer and activator of transcription 1 (STAT1) protein signaling to expand regulatory T cells (Tregs) |
| Q86993409 | Cell-penetrable mouse forkhead box protein 3 alleviates experimental arthritis in mice by up-regulating regulatory T cells |
| Q34276576 | Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation. |
| Q35769049 | Cells of the synovium in rheumatoid arthritis. T lymphocytes. |
| Q84021987 | Cholecystokinin octapeptide exerts its therapeutic effects on collagen-induced arthritis by suppressing both inflammatory and Th17 responses |
| Q30437823 | Clinical applications of mesenchymal stem cells in chronic diseases |
| Q36052152 | Collagen epitope expression on B cells is sufficient to confer tolerance to collagen-induced arthritis |
| Q88788977 | Collagen-induced arthritis in Dark Agouti rats as a model for study of immunological sexual dimorphisms in the human disease |
| Q34994485 | Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. |
| Q42571975 | Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis |
| Q64945673 | Decreased regulatory T-cell frequency and interleukin-35 levels in patients with rheumatoid arthritis. |
| Q35846923 | Dendritic Cell-Specific Deletion of β-Catenin Results in Fewer Regulatory T-Cells without Exacerbating Autoimmune Collagen-Induced Arthritis |
| Q38078552 | Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis. |
| Q33797147 | Differentiated all-trans retinoic acid response of naive CD4+CD25- cells isolated from rats with collagen-induced arthritis and healthy ones under in vitro conditions |
| Q40727194 | Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis |
| Q84644585 | Disturbed Th17/Treg balance in patients with rheumatoid arthritis |
| Q42178524 | Dopamine D2 Receptor Is Involved in Alleviation of Type II Collagen-Induced Arthritis in Mice |
| Q35127503 | Dynamic Frequency of Blood CD4+CD25+ Regulatory T Cells in Rats with Collagen-induced Arthritis |
| Q52726744 | Early Growth Response Gene 2-Expressing CD4+LAG3+ Regulatory T Cells: The Therapeutic Potential for Treating Autoimmune Diseases. |
| Q45080490 | Effect of a cocoa flavonoid-enriched diet on experimental autoimmune arthritis. |
| Q46428308 | Effect of cocoa-enriched diets on lymphocytes involved in adjuvant arthritis in rats |
| Q37868325 | Effector T cells in rheumatoid arthritis: lessons from animal models |
| Q42845326 | Effects of low-dose-gamma rays on the immune system of different animal models of disease |
| Q52608155 | Effects of tamoxifen on estrogen receptor-α level in immune cells and humoral specific response after immunization of C3H/He male mice with syngeneic testicular germ cells (TGC). |
| Q64237012 | Efficient Therapeutic Function and Mechanisms of Human Polyclonal CD8CD103Foxp3 Regulatory T Cells on Collagen-Induced Arthritis in Mice |
| Q39158358 | Engineered regulatory T cells coexpressing MHC class II:peptide complexes are efficient inhibitors of autoimmune T cell function and prevent the development of autoimmune arthritis |
| Q45875046 | Engineering Specificity and Function of Therapeutic Regulatory T Cells. |
| Q37477403 | Enhanced suppressive function of regulatory T cells from patients with immune-mediated diseases following successful ex vivo expansion |
| Q35530818 | Evaluation of immunosuppressive function of regulatory T cells using a novel in vitro cytotoxicity assay |
| Q24299602 | FOXP3 ensembles in T-cell regulation |
| Q34563552 | Fms-like tyrosine kinase 3 ligand controls formation of regulatory T cells in autoimmune arthritis |
| Q41183700 | FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development |
| Q90265133 | Foxp3+ Regulatory T Cells in Bone and Hematopoietic Homeostasis |
| Q36012266 | Gene Therapy Induces Antigen-Specific Tolerance in Experimental Collagen-Induced Arthritis. |
| Q47778027 | Generation of highly effective and stable murine alloreactive Treg cells by combined anti-CD4 mAb, TGF-β, and RA treatment. |
| Q42440899 | Generation of induced regulatory T cells from primary human naïve and memory T cells |
| Q35919096 | Genetic regulation of T regulatory, CD4, and CD8 cell numbers by the arthritis severity loci Cia5a, Cia5d, and the MHC/Cia1 in the rat |
| Q38122210 | Heat shock proteins can be targets of regulatory T cells for therapeutic intervention in rheumatoid arthritis |
| Q93126204 | Helios but not CD226, TIGIT and Foxp3 is a Potential Marker for CD4+ Treg Cells in Patients with Rheumatoid Arthritis |
| Q58780906 | High Interleukin-37 (IL-37) Expression and Increased Mucin-Domain Containing-3 (TIM-3) on Peripheral T Cells in Patients with Rheumatoid Arthritis |
| Q37221779 | High density lipoprotein biogenesis, cholesterol efflux, and immune cell function |
| Q40145396 | Histone methylation mediates plasticity of human FOXP3(+) regulatory T cells by modulating signature gene expressions |
| Q36424891 | Human umbilical cord mesenchymal stem cells as treatment of adjuvant rheumatoid arthritis in a rat model |
| Q64228779 | Humanized Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Cell-Based Therapies |
| Q37536450 | IL-17 down-regulates the immunosuppressive capacity of olfactory ecto-mesenchymal stem cells in murine collagen-induced arthritis |
| Q28249077 | IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells |
| Q35972520 | IL-4/CCL22/CCR4 axis controls regulatory T-cell migration that suppresses inflammatory bone loss in murine experimental periodontitis |
| Q33769303 | IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis |
| Q35954674 | Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis |
| Q92610869 | Immunological adaptations in pregnancy that modulate rheumatoid arthritis disease activity |
| Q37000178 | Immunosuppression by co-stimulatory molecules: inhibition of CD2-CD48/CD58 interaction by peptides from CD2 to suppress progression of collagen-induced arthritis in mice |
| Q34026055 | Impaired thymic export and apoptosis contribute to regulatory T-cell defects in patients with chronic heart failure |
| Q40164249 | In vivo activation of Treg cells with a CD28 superagonist prevents and ameliorates chronic destructive arthritis in mice. |
| Q41160548 | Increased number and function of FoxP3 regulatory T cells during experimental arthritis |
| Q36338863 | Inhibition of cell adhesion and immune responses in the mouse model of collagen-induced arthritis with a peptidomimetic that blocks CD2-CD58 interface interactions |
| Q37690242 | Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis |
| Q37642857 | Intestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunity |
| Q44441249 | Intra-articular nuclear factor-κB blockade ameliorates collagen-induced arthritis in mice by eliciting regulatory T cells and macrophages |
| Q48875369 | Inverse correlation of programmed death 1 (PD-1) expression in T cells to the spinal radiologic changes in Taiwanese patients with ankylosing spondylitis |
| Q37350865 | Is there a feudal hierarchy amongst regulatory immune cells? More than just Tregs |
| Q43174362 | Leflunomide induces immunosuppression in collagen-induced arthritis rats by upregulating CD4+CD25+ regulatory T cells |
| Q34634748 | Local delivery of mesenchymal stem cells with poly-lactic-co-glycolic acid nano-fiber scaffold suppress arthritis in rats |
| Q33869511 | Low CD4/CD8 T-cell ratio associated with inflammatory arthropathy in human T-cell leukemia virus type I Tax transgenic mice |
| Q28083298 | Manipulating regulatory T cells: a promising strategy to treat autoimmunity |
| Q42743507 | Mechanisms of oral tolerance revisited. |
| Q34676250 | Natural regulatory T cells in autoimmunity |
| Q37141166 | Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration |
| Q33583241 | Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis |
| Q44147761 | Numbers of CD25+Foxp3+ T cells that lack the IL-7 receptor are increased intra-articularly and have impaired suppressive function in RA patients |
| Q37635735 | Of mice and men: how animal models advance our understanding of T-cell function in RA. |
| Q38867028 | Oral administration of bovine milk derived extracellular vesicles attenuates arthritis in two mouse models |
| Q37287492 | Parasitic infection as a potential therapeutic tool against rheumatoid arthritis |
| Q50913348 | Pathogenic T cells persist after reversal of autoimmune disease by immunosuppression with regulatory T cells |
| Q82698398 | Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells |
| Q35687041 | Peak inflammation in atherosclerosis, primary biliary cirrhosis and autoimmune arthritis is counter-intuitively associated with regulatory T cell enrichment. |
| Q35923305 | Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury |
| Q36800150 | Phenotypic, Functional, and Gene Expression Profiling of Peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127(low) Treg Cells in Patients With Chronic Rheumatoid Arthritis |
| Q35182029 | Progranulin: a promising therapeutic target for rheumatoid arthritis. |
| Q37386307 | Recent advances in DNA vaccines for autoimmune diseases |
| Q37400302 | Regulation of interferon gamma signaling by suppressors of cytokine signaling and regulatory T cells |
| Q42144593 | Regulatory T cell-mediated control of autoantibody-induced inflammation |
| Q91554671 | Regulatory T cells confer a circadian signature on inflammatory arthritis |
| Q46226178 | Regulatory T cells control VEGF-dependent skin inflammation |
| Q56891124 | Regulatory T cells control epitope spreading in autoimmune arthritis independent of cytotoxic T-lymphocyte antigen-4 |
| Q37311088 | Regulatory T cells in autologous stem cell transplantation for autoimmune disease |
| Q34547120 | Regulatory T cells in experimental autoimmune disease |
| Q82076756 | Regulatory T cells in rheumatoid arthritis |
| Q35872027 | Regulatory T cells protect from autoimmune arthritis during pregnancy |
| Q37855952 | Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity |
| Q36891917 | Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. |
| Q37679455 | Regulatory T-cell vaccination independent of auto-antigen |
| Q37914338 | Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis |
| Q84778300 | Repeated Gamma Irradiation Attenuates Collagen-Induced Arthritis via Up-regulation of Regulatory T Cells but not by Damaging Lymphocytes Directly |
| Q42536113 | Requirement for diverse TCR specificities determines regulatory T cell activity in a mouse model of autoimmune arthritis |
| Q37586940 | Review of tocilizumab in the treatment of rheumatoid arthritis |
| Q48567997 | Review: Transcriptional Regulation of CD4+ T Cell Differentiation in Experimentally Induced Arthritis and Rheumatoid Arthritis |
| Q56656479 | Rheumatoid arthritis |
| Q38497370 | Role of regulatory T cells in rheumatoid arthritis: facts and hypothesis. |
| Q28474036 | Specific immunosuppression with inducible Foxp3-transduced polyclonal T cells |
| Q64076893 | Stem cell-derived tissue-associated regulatory T cells suppress the activity of pathogenic cells in autoimmune diabetes |
| Q82205254 | Study on the Relationship Between Th17 Cells and Unexplained Recurrent Spontaneous Abortion |
| Q35762936 | Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis |
| Q39255811 | T Regulatory Cells in Bone Remodelling |
| Q40168065 | T cell receptor gene therapy for autoimmune diseases |
| Q40159251 | T-cell receptor- and anti-inflammatory gene-modulated T cells as therapy for autoimmune disease |
| Q38224804 | TREG-cell therapies for autoimmune rheumatic diseases. |
| Q93024302 | Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy |
| Q46184995 | Targeting the epitope spreader Pep19 by naïve human CD45RA+ regulatory T cells dictates a distinct suppressive T cell fate in a novel form of immunotherapy. |
| Q64244855 | Th lymphocyte subsets in patients with Vogt-Koyanagi-Harada disease |
| Q90661480 | Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis |
| Q86906663 | The Activation of NF-κB in Infiltrated Mononuclear Cells Negatively Correlates with Treg Cell Frequency in Oral Lichen Planus |
| Q40117186 | The CII-specific autoimmune T-cell response develops in the presence of FTY720 but is regulated by enhanced Treg cells that inhibit the development of autoimmune arthritis. |
| Q36992773 | The Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells |
| Q24633549 | The PD-1 pathway in tolerance and autoimmunity |
| Q36131101 | The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis |
| Q33892797 | The attenuation of renal fibrosis by histone deacetylase inhibitors is associated with the plasticity of FOXP3+IL-17+ T cells |
| Q89422869 | The chemokine receptor CCR7 is a promising target for rheumatoid arthritis therapy |
| Q57673817 | The prothrombinase activity of FGL2 contributes to the pathogenesis of experimental arthritis |
| Q36875765 | The remission of rheumatoid arthritis during pregnancy |
| Q37199648 | The role of regulatory T cells in multiple sclerosis |
| Q50434732 | The therapeutic efficacy of human adipose tissue-derived mesenchymal stem cells on experimental autoimmune hearing loss in mice |
| Q28080019 | The thymus and rheumatology: should we care? |
| Q33684806 | Therapeutic potential of TGF-β-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases. |
| Q58296252 | Therapeutic potential of autologous mesenchymal stem cells derived from synovial fluid in patients with degenerative arthritis |
| Q24612869 | Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis |
| Q38098467 | Therapeutic potential of regulatory T cells in autoimmune disorders. |
| Q42116282 | Therapy for pneumonitis and sialadenitis by accumulation of CCR2-expressing CD4+CD25+ regulatory T cells in MRL/lpr mice |
| Q37186819 | Toll-like receptor signalling on Tregs: to suppress or not to suppress? |
| Q43985688 | Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis |
| Q37750140 | Treating arthritis by immunomodulation: is there a role for regulatory T cells? |
| Q36830470 | Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders |
| Q33822653 | Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis |
| Q33733295 | Use of immune modulation by human adipose-derived mesenchymal stem cells to treat experimental arthritis in mice |
| Q37253229 | Xianfanghuomingyin, a Chinese Compound Medicine, Modulates the Proliferation and Differentiation of T Lymphocyte in a Collagen-Induced Arthritis Mouse Model |
| Q54492304 | [Use of regulatory T cells in cellular therapies in autoimmune diseases]. |
Search more.